In a trial, men who received stereotactic body radiotherapy (SBRT) didn’t have a higher risk of cancer recurrence than men treated with other common radiation therapy regimens that are given over longer periods.
Black people with cancer are much less likely to join clinical trials than White patients. Results from a new study may help explain why and help research staff talk with and recruit more Black participants.
In a nearly 1,000-patient trial, treatment with nivolumab (Opdivo) and the chemotherapy regimen AVD was better at eliminating cancer and keeping it at bay than the current standard initial treatment for the disease, AVD and brentuximab (Adcetris). The nivolumab combination also had fewer side effects.
On Monday, new recommendations from a panel of independent experts (NutriRECS https://nutrirecs.com/about/) say that most people can continue to consume red and processed meat at their average current consumption levels. We asked nutritional epidemiologist Marji McCullough, ScD RD, about the … Continue reading →
A randomized clinical trial comparing two types of surgery in people with localized muscle-invasive bladder cancer found that more extensive surgery removing a larger group of lymph nodes did not improve survival, compared with standard lymph node surgery.